UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort

Luotola, K; Jyväkorpi, S; Urtamo, A; Pitkälä, KH; Kivimäki, M; Strandberg, TE; (2020) Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort. Age & Ageing , 49 (2) 10.1093/ageing/afz138. Green open access

[thumbnail of Statin Treatment.pdf]
Preview
Text
Statin Treatment.pdf - Accepted Version

Download (241kB) | Preview

Abstract

BACKGROUND: statin treatment has increased also among people aged 80 years and over, but adverse effects potentially promoting frailty and loss of resilience are frequent concerns. METHODS: in the Helsinki Businessmen Study, men born in 1919-34 (original n = 3,490) have been followed up since the 1960s. In 2011, a random subcohort of home-living survivors (n = 525) was assessed using questionnaires and clinical (including identification of phenotypic frailty) and laboratory examinations. A 7-year mortality follow-up ensued. RESULTS: we compared 259 current statin users (median age 82 years, interquartile range 80-85 years) with 266 non-users (83; 80-86 years). Statin users had significantly more multimorbidity than non-users (prevalencies 72.1% and 50.4%, respectively, P < 0.0001) and worse glucose status than non-users (prevalencies of diabetes 19.0% and 9.4%, respectively, P = 0.0008). However, there was no difference in phenotypic frailty (10.7% versus 11.2%, P = 0.27), and statin users had higher plasma prealbumin level than non-users (mean levels 257.9 and 246.3 mg/L, respectively, P = 0.034 adjusted for age, body mass index and C-reactive protein) implying better nutritional status. Despite morbidity difference, age-adjusted 7-year mortality was not different between the two groups (98 and 103 men among users and non-users of statins, respectively, hazard ratio 0.96, 95% confidence interval 0.72-1.30). CONCLUSIONS: our study suggests that male octogenarian statin users preserved resilience and survival despite multimorbidity, and this may be associated with better nutritional status among statin users.

Type: Article
Title: Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/ageing/afz138
Publisher version: https://doi.org/10.1093/ageing/afz138
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: cardiovascular disease, cholesterol, metabolic, nutrition, older people, prealbumin
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Epidemiology and Public Health
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10089527
Downloads since deposit
2,432Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item